Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappaB1 DNA binding domain (Q33284189)

25 July 2017

Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappaB1 DNA binding domain (English)

1 reference

25 July 2017

Cherie Lambert

1

1 reference

25 July 2017

Jimei Li

2

1 reference

25 July 2017

Karen Jonscher

3

1 reference

25 July 2017

Teng-Chieh Yang

4

1 reference

25 July 2017

Philip Reigan

5

1 reference

25 July 2017

Megan Quintana

6

1 reference

25 July 2017

Jean Harvey

7

1 reference

25 July 2017

Brian M Freed

8

1 reference

25 July 2017

language of work or name

English

0 references

publication date

9 May 2007

1 reference

Journal of Biological Chemistry

25 July 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

25 July 2017

282

1 reference

25 July 2017

27

1 reference

25 July 2017

19666-19675

1 reference

Clearing the smoke: the science base for tobacco harm reduction--executive summary

25 July 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Cellular immunity in mice chronically exposed to fresh cigarette smoke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Hydroquinone and catechol interfere with T cell cycle entry and progression through the G1 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Differential inhibition of DNA synthesis in human T cells by the cigarette tar components hydroquinone and catechol

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Cigarette tar phenols impede T cell cycle progression by inhibiting cyclin-dependent kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Acrolein in cigarette smoke inhibits T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Inhibition of NFkappaB activation and IL-8 expression in human bronchial epithelial cells by acrolein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Inhibition of cell proliferation and AP-1 activity by acrolein in human A549 lung adenocarcinoma cells due to thiol imbalance and covalent modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Upregulation of endothelial heme oxygenase-1 expression through the activation of the JNK pathway by sublethal concentrations of acrolein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Induction of phase 2 enzymes by serum oxidized polyamines through activation of Nrf2: effect of the polyamine metabolite acrolein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Acrolein causes transcriptional induction of phase II genes by activation of Nrf2 in human lung type II epithelial (A549) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

NF-kappaB and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Missing pieces in the NF-kappaB puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Effect of acrolein and glutathione depleting agents on thioredoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Thiolation of protein-bound carcinogenic aldehyde. An electrophilic acrolein-lysine adduct that covalently binds to thiols

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Identification of glutathione modifications by cigarette smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Cigarette smoke impairs neutrophil respiratory burst activation by aldehyde-induced thiol modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

The activity of NF-kappaB in Swiss 3T3 cells exposed to aqueous extracts of cigarette smoke is dependent on thioredoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Induction of thioredoxin reductase as an adaptive response to acrolein in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

The Paf1 complex has functions independent of actively transcribing RNA polymerase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

N(epsilon)-(3-methylpyridinium)lysine, a major antigenic adduct generated in acrolein-modified protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Acrolein modifies apolipoprotein A-I in the human artery wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts".

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Role of cysteine62 in DNA recognition by the P50 subunit of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Inhibition of NF-kappaB DNA binding by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T lymphocytes. Evidence for covalent modification of the p50 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

15-deoxy-Delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsatu

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611527200

21 January 2018

Identifiers

DOI

10.1074/JBC.M611527200

1 reference

release_uqubrznyhbdrvdpg2soejmkobi

25 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uqubrznyhbdrvdpg2soejmkobi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference